Preclinical Program for Targeting Myobacterium tuberculosis KasA
Summary
We will use mouse infection models with virulent Mycobacterium tuberculosis to evaluate the anti-tuberculosis activity of JSF-3285 alone and in combination with other TB drugs used clinically or in clinical development.